Stock DNA
Pharmaceuticals & Biotechnology
JPY 9,157 Million (Micro Cap)
10.00
NA
0.06%
0.19
5.93%
0.70
Revenue and Profits:
Net Sales:
2,261 Million
(Quarterly Results - Jun 2025)
Net Profit:
33 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.56%
0%
2.56%
6 Months
9.63%
0%
9.63%
1 Year
18.04%
0%
18.04%
2 Years
14.88%
0%
14.88%
3 Years
8.4%
0%
8.4%
4 Years
-0.91%
0%
-0.91%
5 Years
-17.74%
0%
-17.74%
Koken Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.20%
EBIT Growth (5y)
7.99%
EBIT to Interest (avg)
24.25
Debt to EBITDA (avg)
1.82
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.58
Tax Ratio
26.32%
Dividend Payout Ratio
23.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.16%
ROE (avg)
6.43%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.66
EV to EBIT
9.35
EV to EBITDA
6.78
EV to Capital Employed
0.71
EV to Sales
0.97
PEG Ratio
0.18
Dividend Yield
0.06%
ROCE (Latest)
7.54%
ROE (Latest)
6.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
2,260.60
2,830.30
-20.13%
Operating Profit (PBDIT) excl Other Income
177.30
460.70
-61.52%
Interest
17.30
10.60
63.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
33.40
260.50
-87.18%
Operating Profit Margin (Excl OI)
34.30%
128.80%
-9.45%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -20.13% vs -24.32% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -87.18% vs -36.83% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
10,762.40
10,587.10
1.66%
Operating Profit (PBDIT) excl Other Income
1,451.00
1,497.60
-3.11%
Interest
47.50
45.80
3.71%
Exceptional Items
31.60
0.00
Consolidate Net Profit
722.10
701.10
3.00%
Operating Profit Margin (Excl OI)
93.80%
95.20%
-0.14%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.66% vs -0.16% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 3.00% vs -15.84% in Dec 2023
About Koken Ltd. 
Koken Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






